)
Gabi Tarcic
Chief Development Officer
Evogene Ltd.
Dr. Gabi Tarcic joined Evogene in 2024 and was appointed as Evogene’s Chief Development Officer in January 2026. Dr. Tarcic has extensive experience in research and development projects and as a senior executive in the biotech industry. Prior to joining Evogene, Dr. Tarcic has served in various positions at Fore Biotherapeutics (formerly NovellusDx Israel), most recently as its Chief Technology Officer.
Dr. Tarcic holds a Ph.D. in life sciences from The Weizmann Institute of Science, Israel.
Sessions
-
23-Jun-2026Theater 1Evogene
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}